Tagged With: Schedule
DEA Reclassifies Plant-Derived Marijuana Medicine To Schedule V
Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified today by the US Drug Enforcement Administration to Schedule V — the lowest restriction classification available under federal law. The US Food and Drug Administration had previously approved the product in June for the explicit treatment of two rare forms … Continue reading
Kentucky: Cannabis Activists Schedule Educational Forum in Henderson
There will be an educational forum on the benefits that medicinal cannabis has to offer to Kentucky and its citizens. Featuring support from state cannabis activists including members from Kentucky Cannabis Freedom Coalition (KCFC), Kentucky affiliate for the National Organization for the Reform of Marijuana Laws (KY NORML), Kentuckians for Medicinal Marijuana (KY4MM), the Alliance … Continue reading
Federal Judge Dismisses Lawsuit Challenging Marijuana’s Schedule I Prohibited Status
A federal district court judge in Manhattan today granted the government’s motion to dismiss a lawsuit that sought to challenge the constitutionality of cannabis’ prohibited status under federal law. The 98-page complaint, filed in July 2017 by a legal team that includes New York attorney Michael Hiller, NORML Legal Committee member Joseph Bondy and Empire … Continue reading
DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise
The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … … Continue reading
